This inventor holds 1 USPTO granted patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Nischal Vinodbhai Patel: Innovator in Antidepressant Compounds
Introduction
Nischal Vinodbhai Patel is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressant compounds. His work is characterized by a commitment to innovation and the advancement of medicinal chemistry.
Latest Patents
Nischal holds a patent for a process for the preparation of an antidepressant compound. The invention provides optically pure (S)-(+)-N-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine, a compound of formula (I). Additionally, it includes the optically pure (S)-isomer of a compound of formula (IV), where R and R' can be methyl, or R is methyl and R' is a benzyl or substituted benzyl group. The patent also outlines a process for the preparation of an acid addition salt of compound (I).
Career Highlights
Nischal is currently employed at Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions for mental health treatments. His dedication to his work has led to the successful patenting of his antidepressant compound.
Collaborations
Nischal has collaborated with notable colleagues, including Rajeev Budhdev Rehani and Kartik Shantilal Patel. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Nischal Vinodbhai Patel is a distinguished inventor whose work in the field of antidepressant compounds showcases his innovative spirit and dedication to improving mental health treatments. His contributions to the pharmaceutical industry are commendable and reflect his commitment to advancing medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
